Serum Institute to Begin Phase Two Trial of Oxford Covid-19 Vaccine Candidate Today

Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford.

Read the Rest at News18

Leave a Reply

Your email address will not be published. Required fields are marked *